CNS Pharmaceuticals Company Presentation

CNS pharmaceuticals 19 Financial Profile. CNS Pharmaceuticals, Inc. (Nasdaq: CNSP) Cash and Cash Equivalents as of June 30, 2020 • $2.6 million Initial Public Offering Nov. 13, 2019 • $9.8 million in gross proceeds Shares outstanding as of June 30, 2020 • 16.5 million Options and Warrants outstanding as of June 30, 2020 • 4.0 million warrants at a WAEP of $3.99 • 2.3 million options at a WAEP of $2.01